For Science and Technology Industry Entrepreneurs and Start Up Companies
102
page-template-default,page,page-id-102,page-child,parent-pageid-16067,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.1.3,wpb-js-composer js-comp-ver-4.11.2.1,vc_responsive
 

Cubresa

Home > Showcase > Cubresa

One Line Pitch:  Cubresa builds SPECT and PET cameras for retro fit to current single imaging devices such as CT scanners and MRI.  

Business Summary:  The Company is building small SPECT and PET cameras for pre-clinical (animal) researchers who research the effectiveness of drugs in tumor management. 

Management: James Schellenberg graduated from the University of Manitoba in 1990 with a Ph.D. (EE).  His expertise stems from 20 years of start-up experience, which includes 12 years in telecom and 8 years in medical imaging, including the position of VP-R&D for IMRIS.  Harry Ethans is a seasoned M&A executive.

Customer Problem: Clinical research organizations (CROs) need to migrate to multi-modal imaging to provide a competitive service.  Many have existing infrastructure which has only single-purpose imaging capacity.  The current solution is to dispose of existing devices single-purpose devices and purchase new devices with SPECT and PET embedded by the OEM.

Product / Services:  Cubresa manufactures, sells and services retro fit SPECT and PET cameras including the electronics and software for integration.    

Market Value Propositions: Cost-effective approach for CROs to update aging infrastructure.

Target Market and Customers: Our target market are CROs with single-modality imaging devices.  This customer base represents a total of $12 billion of sales for Cubresa.

Business Model: Cubresa invents, designs, manufactures and markets the equipment to channel partners and directly to CROs depending on the geographic region.    

Competitive Advantage:  This is a unique patented approach that offers co-registered MRI and Gamma images for improved pre-clinical analysis.        

Accomplishments: 

  • Raised over $1 M in equity investments
  • Built a world class science team.
  • Early adopter customers using the devices. 

Competitors:  Bruker’s Albira, VECTor and MEdiso are all new devices which offer multi-modal imaging.  Cubresa is the only after-market addition currently available.

Next Steps:  Secure a second technology patent in PET and an international customer.

 

Apply for the business incubation program today.